{"product_id":"on-body-drug-delivery-devices-intellectual-property-landscape-focus-on-popular-relevant-prior-art-search-expressions-patent-valuation-pockets-of-innovation-white-spaces-and-key-applicant-profiles","title":"On-body Drug Delivery Devices - Intellectual Property Landscape: Focus on Popular \/ Relevant Prior Art Search Expressions, Patent Valuation, Pockets of Innovation \/ White Spaces, and Key Applicant Profiles","description":"\u003cp\u003eOn-body Drug Delivery Devices - Intellectual Property Landscape: Focus on Popular \/ Relevant Prior Art Search Expressions, Patent Valuation, Pockets of Innovation \/ White Spaces, and Key Applicant Profiles\u003c\/p\u003e\n\n\n\n\u003cp\u003eChronic diseases, such as diabetes, arthritis, hypertension and cancer, are considered among the leading causes of death, worldwide. In fact, a recent study revealed that the global failure to control the steady rise in preventable risk factors associated with the aforementioned conditions, rendered populations vulnerable to COVID-19. Although there are several national and global-level initiatives focused on educating the masses on prevention and promote healthy living, individuals living with a chronic medical condition are required to medicate on a frequent basis – which is often multiple times in a single day. Lack of adherence to prescribed medication regimens (due to various reasons) and high cost of treatment (a significant share of which stems from non-compliance to treatment), are the major contributing factors to the associated burden on patients and the healthcare system. However, modern therapy administration technology, such as wearable and implantable drug delivery solutions, allows patients to effectively deal with several of the areas of concern related to therapy adherence and treatment costs.\u003c\/p\u003e \n\n\n\n\u003cp\u003eWith provisions to adhere to, or be implanted in the body, this advanced category of drug delivery solutions are known to (1) enable patients to self-medicate (thereby, saving on routine hospital visit fees), (2) effectively reduce the number of needle-pricks in case of patients who are required to medicate multiple times in a day, (3) administer large volumes (more than 2 mL) of therapeutic formulations over an extended period of time, and (4) improve compliance to therapeutic regimens (some devices include provisions for monitoring \/ tracking dosing). The advantages of on-body drug delivery devices are numerous; consequently, the demand for such devices is also high and growing, which is projected to grow to a USD 600 million market by 2030. Within such a lucrative and rapidly evolving market it is imperative for innovators and other stakeholders (including interested investors) to regularly track the growing intellectual capital. In this context, we have analyzed the intellectual property landscape related to on-body (wearable and implantable) drug delivery solutions, and developed independent opinions on both historical and recent trends, and other key attributes of the innovation in this upcoming field of medical technology.\u003c\/p\u003e \n\n\n\n\u003cp\u003eSCOPE OF THE REPORT\u003c\/p\u003e\n\n\u003cp\u003eThe “On-body Drug Delivery Devices - Intellectual Property Landscape” report features an extensive study of the historical and current collection of granted patents, patent applications and affiliated documents associated with modern wearable \/ implantable therapy administration solutions. The information in this report has been presented across two deliverables, namely an Excel sheet, featuring an interactive dashboard, and a PowerPoint presentation, summarizing the ongoing activity in this domain, and key insights drawn from the available data. The report features the following details:\u003c\/p\u003e\n\n\n\n\u003cp\u003eOverall Intellectual Property Landscape\u003c\/p\u003e\n\n\u003cp\u003eAn in-depth analysis of the various patents and affiliated IP documents that have been published related to technologies and methods associated with wearable \/ implantable drug delivery devices, featuring key insights from historical and recent trends\u003c\/p\u003e\n\n\u003cp\u003ePopular \/ Relevant Prior Art Search Expressions\u003c\/p\u003e\n\n\u003cp\u003eAn examination of IP literature, identifying key words and phrases that are used to describe innovations in portable, large volume drug dispensing solutions, including information on historical usage in IP filings, key affiliated terms (which can be used to further identify similar innovations), and other related trends\u003c\/p\u003e\n\n\u003cp\u003ePatent Valuation Analysis\u003c\/p\u003e\n\n\u003cp\u003eA competitive benchmarking and valuation analysis, taking into account important IP associated parameters, such as type of IP document, year of application, time to expiry, number of citations and jurisdiction (taking into consideration regional GDP), where the IP application was filed\u003c\/p\u003e\n\n\u003cp\u003ePockets of Innovation and White Spaces\u003c\/p\u003e\n\n\u003cp\u003eAn analysis of the CPC symbols and affiliated families, to identify historical and existing pockets of innovation, featuring an insightful discussion on the prevalent white spaces in this area of research\u003c\/p\u003e\n\n\u003cp\u003eCompany Profiles\u003c\/p\u003e\n\n\u003cp\u003eDetailed profiles of the key players that have the maximum number of IP publication in the period between 2001-2021, including overview of the company, financial information (if available), and its proprietary IP related trends\u003c\/p\u003e\n\n\n\n\u003cp\u003eRESEARCH METHODOLOGY\u003c\/p\u003e\n\n\u003cp\u003eThe data presented in this report has been gathered via secondary research and analyzed via proprietary methods \/ tools to develop a detailed perspective on the current status of the developer landscape across different global regions. Where possible, the available data has been checked for accuracy from multiple sources of information.\u003c\/p\u003e\n\n\n\n\u003cp\u003eThe secondary sources of information include\u003c\/p\u003e \n\n\u003cp\u003eCompany websites\u003c\/p\u003e \n\n\u003cp\u003eAnnual reports\u003c\/p\u003e\n\n\u003cp\u003eInvestor presentations\u003c\/p\u003e\n\n\u003cp\u003eIndustry databases\u003c\/p\u003e\n\n\u003cp\u003ePress releases\u003c\/p\u003e \n\n\u003cp\u003eGovernment policy documents\u003c\/p\u003e\n\n\u003cp\u003eClinical trial registries \/ databases (such as www.clinicaltrials.gov)\u003c\/p\u003e \n\n\u003cp\u003eIndustry analysts’ views\u003c\/p\u003e\n\n\n\n\u003cp\u003eThe insights presented are solely based on our knowledge, research and understanding of the relevant market, as gathered from various secondary sources of information.\u003c\/p\u003e\n\n\n\n\u003cp\u003eDELIVERABLE OUTLINES\u003c\/p\u003e\n\n\u003cp\u003eExcel Deliverable\u003c\/p\u003e\n\n\u003cp\u003e1. The first section of the spreadsheet features details on how the input data for this project was collated, including the search strings used to query the lens.org patent database and noise removal criteria.\u003c\/p\u003e\n\n\n\n\u003cp\u003e2. The second section of the deliverable is a summary MS Excel dashboard, offering a detailed graphical perspective of the intellectual property landscape of on-body drug delivery solutions, highlighting trends key patent \/ patent application publication trends, CPC symbol usage over time and intellectual capital-related publication trends of key applicants that are engaged in this industry\u003c\/p\u003e \n\n\n\n\u003cp\u003e3. The third section of the spreadsheet is an elaborate table, which features a long list of all the intellectual capital (namely granted patents, patent applications, limited patents, amended patents, abstracts, statutory invention registration and search reports) related publications, for which the relevant details are available in the public domain.\u003c\/p\u003e \n\n\n\n\u003cp\u003e4. The next section of the deliverable includes an analysis of the key CPC symbols, highlighting usage trends (since 2001) related to the top CPC symbol and CPC families, used by innovators in this field of medical technology to describe their respective products \/ technologies \/ methods of use.\u003c\/p\u003e\n\n\n\n\u003cp\u003e5. The final section of the deliverable includes an analysis of the key applicants that have published the various types of intellectual property documents that have been considered in this report. It also features another table, which includes information on the top 25 applicants, based on the number of intellectual capital related publications, in the period 2001-2021\u003c\/p\u003e \n\n\n\n\u003cp\u003ePowerPoint Deliverable\u003c\/p\u003e\n\n\u003cp\u003e1. The first part of this deliverable features an executive summary of the key insights generated from analyzing the intellectual property landscape associated with on-body drug delivery devices.\u003c\/p\u003e\n\n\n\n\u003cp\u003e2. The next part provides important details related to on-body drug delivery devices, including key product related definitions, advantages of the technology and the methodology used (in this project) to query the public database, lens.org, for information on the published intellectual capital related to this innovation.\u003c\/p\u003e\n\n\n\n\u003cp\u003e3. The third section of the deliverable includes charts and figures describing the overall intellectual property landscape of on-body drug delivery devices and affiliated technologies \/ methods of use.\u003c\/p\u003e \n\n\n\n\u003cp\u003e4. The next section of the deliverable includes charts and figures describing the intellectual property landscape of on-body drug delivery devices and affiliated technologies \/ methods of use, since 2001.\u003c\/p\u003e \n\n\n\n\u003cp\u003e5. The subsequent section features insights from a detailed analysis of the titles of patent \/ patent applications related to wearable and implantable drug delivery solutions. It includes multiple word clouds, which help identify the most important keywords that can be used for prior art research specific to this field.\u003c\/p\u003e \n\n\n\n\u003cp\u003e6. The sixth section provides our independent views on the relative valuation of the intellectual property related to on-body drug delivery devices, taking into account important associated parameters, such as type of document, year of application, time to expiry, number of citations and jurisdiction (taking into consideration regional GDP), where the IP application was filed.\u003c\/p\u003e\n\n\n\n\u003cp\u003e7. The next section features an analysis of the CPC symbols and affiliated families, to identify historical and existing pockets of innovation, and also includes an insightful discussion on the prevalent white spaces in this area of research.\u003c\/p\u003e\n\n\n\n\u003cp\u003e8. Finally, it includes profiles of the companies having the maximum number of intellectual capital related publication in the period between 2001-2021, including overview of the company, financial information (if available), and its proprietary intellectual property publication related trends.\u003c\/p\u003e\n\n\n\n\u003cp\u003eLIST OF COMPANIES \/ LIST OF COMPANIES AND ORGANIZATIONS\u003c\/p\u003e\n\n\n\n\u003cp\u003eThe following companies and organizations have been mentioned in the report.\u003c\/p\u003e\n\n\u003cp\u003e1. 3D Medicines\u003c\/p\u003e \n\n\u003cp\u003e2. 3M\u003c\/p\u003e\n\n\u003cp\u003e3. 89Bio\u003c\/p\u003e\n\n\u003cp\u003e4. AB2 Bio\u003c\/p\u003e\n\n\u003cp\u003e5. Abbott\u003c\/p\u003e\n\n\u003cp\u003e6. AbbVie\u003c\/p\u003e\n\n\u003cp\u003e7. AbGenomics\u003c\/p\u003e\n\n\u003cp\u003e8. Ablynx\u003c\/p\u003e\n\n\u003cp\u003e9. Acceleron Pharma\u003c\/p\u003e\n\n\u003cp\u003e10. Accenture\u003c\/p\u003e\n\n\u003cp\u003e11. Acer Therapeutics\u003c\/p\u003e\n\n\u003cp\u003e12. ADC Therapeutics\u003c\/p\u003e\n\n\u003cp\u003e13. Adisave\u003c\/p\u003e\n\n\u003cp\u003e14. Adrenomed\u003c\/p\u003e\n\n\u003cp\u003e15. Aduro BioTech\u003c\/p\u003e\n\n\u003cp\u003e16. Advaxis\u003c\/p\u003e\n\n\u003cp\u003e17. Aeglea BioTherapeutics\u003c\/p\u003e\n\n\u003cp\u003e18. Aetna\u003c\/p\u003e\n\n\u003cp\u003e19. Affibody\u003c\/p\u003e\n\n\u003cp\u003e20. Affimed\u003c\/p\u003e\n\n\u003cp\u003e21. Affinivax\u003c\/p\u003e\n\n\u003cp\u003e22. Agenus\u003c\/p\u003e\n\n\u003cp\u003e23. AgonOx\u003c\/p\u003e\n\n\u003cp\u003e24. Akcea Therapeutics\u003c\/p\u003e\n\n\u003cp\u003e25. Akero Therapeutics\u003c\/p\u003e\n\n\u003cp\u003e26. Akeso Tiancheng\u003c\/p\u003e\n\n\u003cp\u003e27. Akesobio Australia\u003c\/p\u003e\n\n\u003cp\u003e28. Alder BioPharmaceuticals\u003c\/p\u003e\n\n\u003cp\u003e29. Alector\u003c\/p\u003e\n\n\u003cp\u003e30. Alexion Pharmaceuticals\u003c\/p\u003e\n\n\u003cp\u003e31. Alkahest\u003c\/p\u003e\n\n\u003cp\u003e32. Alkermes\u003c\/p\u003e\n\n\u003cp\u003e33. Allakos\u003c\/p\u003e\n\n\u003cp\u003e34. Allergan\u003c\/p\u003e\n\n\u003cp\u003e35. Allozyne\u003c\/p\u003e\n\n\u003cp\u003e36. Alnylam Pharmaceuticals\u003c\/p\u003e\n\n\u003cp\u003e37. Alopexx Oncology\u003c\/p\u003e\n\n\u003cp\u003e38. AlphaCore Pharma\u003c\/p\u003e\n\n\u003cp\u003e39. Alphamab\u003c\/p\u003e\n\n\u003cp\u003e40. Altor BioScience\u003c\/p\u003e\n\n\u003cp\u003e41. Ambrx\u003c\/p\u003e\n\n\u003cp\u003e42. Amgen\u003c\/p\u003e\n\n\u003cp\u003e43. Amicus Therapeutics\u003c\/p\u003e\n\n\u003cp\u003e44. Amphivena Therapeutics\u003c\/p\u003e\n\n\u003cp\u003e45. Amplyx Pharmaceuticals\u003c\/p\u003e\n\n\u003cp\u003e46. AnaptysBio\u003c\/p\u003e\n\n\u003cp\u003e47. Andes Biotechnologies\u003c\/p\u003e\n\n\u003cp\u003e48. Angiochem\u003c\/p\u003e\n\n\u003cp\u003e49. Antares Pharma\u003c\/p\u003e\n\n\u003cp\u003e50. Antaros Medical\u003c\/p\u003e\n\n\u003cp\u003e51. Apellis Pharmaceuticals\u003c\/p\u003e\n\n\u003cp\u003e52. Aptevo Therapeutics\u003c\/p\u003e\n\n\u003cp\u003e53. Araclon Biotech\u003c\/p\u003e\n\n\u003cp\u003e54. argenx\u003c\/p\u003e \n\n\u003cp\u003e55. Argos Therapeutics\u003c\/p\u003e\n\n\u003cp\u003e56. ArmaGen\u003c\/p\u003e\n\n\u003cp\u003e57. ARMO BioSciences\u003c\/p\u003e\n\n\u003cp\u003e58. Aronora\u003c\/p\u003e\n\n\u003cp\u003e59. Arrowhead Pharmaceuticals\u003c\/p\u003e\n\n\u003cp\u003e60. Asante Solutions\u003c\/p\u003e\n\n\u003cp\u003e61. Ascendis Pharma\u003c\/p\u003e\n\n\u003cp\u003e62. Ascensia Diabetes Care\u003c\/p\u003e\n\n\u003cp\u003e63. ASIT Biotech\u003c\/p\u003e\n\n\u003cp\u003e64. Asklepion Pharmaceuticals\u003c\/p\u003e\n\n\u003cp\u003e65. ASLAN Pharmaceuticals\u003c\/p\u003e\n\n\u003cp\u003e66. Astellas Pharma\u003c\/p\u003e\n\n\u003cp\u003e67. Astorg\u003c\/p\u003e\n\n\u003cp\u003e68. AstraZeneca\u003c\/p\u003e\n\n\u003cp\u003e69. Atridia\u003c\/p\u003e\n\n\u003cp\u003e70. Australasian Medical \u0026amp; Scientific\u003c\/p\u003e\n\n\u003cp\u003e71. Avillion\u003c\/p\u003e\n\n\u003cp\u003e72. Axon Neuroscience\u003c\/p\u003e\n\n\u003cp\u003e73. Baril\u003c\/p\u003e \n\n\u003cp\u003e74. Basilea Pharmaceutica\u003c\/p\u003e\n\n\u003cp\u003e75. Bastian Solutions\u003c\/p\u003e\n\n\u003cp\u003e76. Battelle\u003c\/p\u003e\n\n\u003cp\u003e77. Bavarian Nordic\u003c\/p\u003e\n\n\u003cp\u003e78. Baxalta\u003c\/p\u003e\n\n\u003cp\u003e79. Baxter International\u003c\/p\u003e\n\n\u003cp\u003e80. Bayer\u003c\/p\u003e\n\n\u003cp\u003e81. Bayhill Therapeutics\u003c\/p\u003e\n\n\u003cp\u003e82. Becton Dickinson\u003c\/p\u003e\n\n\u003cp\u003e83. BeiGene\u003c\/p\u003e\n\n\u003cp\u003e84. Beijing Dongfang Biotech\u003c\/p\u003e\n\n\u003cp\u003e85. Beijing Northland Biotech\u003c\/p\u003e\n\n\u003cp\u003e86. Bern University\u003c\/p\u003e\n\n\u003cp\u003e87. Bespak\u003c\/p\u003e\n\n\u003cp\u003e88. Beta Bionics\u003c\/p\u003e\n\n\u003cp\u003e89. Bigfoot Biomedical\u003c\/p\u003e\n\n\u003cp\u003e90. BioArctic\u003c\/p\u003e\n\n\u003cp\u003e91. BIOCAD\u003c\/p\u003e\n\n\u003cp\u003e92. Biocon\u003c\/p\u003e\n\n\u003cp\u003e93. Biogen\u003c\/p\u003e\n\n\u003cp\u003e94. BioIntegrator\u003c\/p\u003e\n\n\u003cp\u003e95. Bioject Medical Technologies\u003c\/p\u003e\n\n\u003cp\u003e96. BioMarin Pharmaceutical\u003c\/p\u003e\n\n\u003cp\u003e97. Biomay\u003c\/p\u003e\n\n\u003cp\u003e98. BioMimetix\u003c\/p\u003e\n\n\u003cp\u003e99. Bioniz Therapeutics\u003c\/p\u003e\n\n\u003cp\u003e100. BioNTech\u003c\/p\u003e\n\n\u003cp\u003e101. Bio-Path Holdings\u003c\/p\u003e\n\n\u003cp\u003e102. Biotest Pharmaceuticals\u003c\/p\u003e\n\n\u003cp\u003e103. Bio-Thera Solutions\u003c\/p\u003e\n\n\u003cp\u003e104. BJ Bioscience\u003c\/p\u003e\n\n\u003cp\u003e105. Boehringer Ingelheim\u003c\/p\u003e\n\n\u003cp\u003e106. Boston Pharmaceuticals\u003c\/p\u003e\n\n\u003cp\u003e107. Buehler Motor\u003c\/p\u003e\n\n\u003cp\u003e108. Calando Pharmaceuticals\u003c\/p\u003e\n\n\u003cp\u003e109. Calibr\u003c\/p\u003e\n\n\u003cp\u003e110. Calibra Medical\u003c\/p\u003e\n\n\u003cp\u003e111. Cam Med\u003c\/p\u003e\n\n\u003cp\u003e112. CANbridge Life Sciences\u003c\/p\u003e\n\n\u003cp\u003e113. Cancer Advances\u003c\/p\u003e\n\n\u003cp\u003e114. Cara Therapeutics\u003c\/p\u003e\n\n\u003cp\u003e115. Cardiome Pharma\u003c\/p\u003e\n\n\u003cp\u003e116. Care Innovations\u003c\/p\u003e\n\n\u003cp\u003e117. CareFusion\u003c\/p\u003e\n\n\u003cp\u003e118. Catalyst Biosciences\u003c\/p\u003e\n\n\u003cp\u003e119. Celgene\u003c\/p\u003e\n\n\u003cp\u003e120. Celldex Therapeutics\u003c\/p\u003e\n\n\u003cp\u003e121. CEL-SCI\u003c\/p\u003e\n\n\u003cp\u003e122. CeQur\u003c\/p\u003e\n\n\u003cp\u003e123. Changchun BCHT Biotechnology\u003c\/p\u003e\n\n\u003cp\u003e124. Chimerix\u003c\/p\u003e\n\n\u003cp\u003e125. CHO Pharma\u003c\/p\u003e\n\n\u003cp\u003e126. Chugai Pharmaceutical\u003c\/p\u003e\n\n\u003cp\u003e127. CiVi Biopharma\u003c\/p\u003e\n\n\u003cp\u003e128. Cleveland BioLabs\u003c\/p\u003e\n\n\u003cp\u003e129. Conjupro Biotherapeutics\u003c\/p\u003e\n\n\u003cp\u003e130. Consort Medical\u003c\/p\u003e\n\n\u003cp\u003e131. ContraFect\u003c\/p\u003e\n\n\u003cp\u003e132. ConvaTec\u003c\/p\u003e\n\n\u003cp\u003e133. Cordant Group\u003c\/p\u003e\n\n\u003cp\u003e134. Corvidia Therapeutics\u003c\/p\u003e\n\n\u003cp\u003e135. Cour Pharmaceutical Development\u003c\/p\u003e\n\n\u003cp\u003e136. CRISI Medical Systems\u003c\/p\u003e\n\n\u003cp\u003e137. CSL Behring\u003c\/p\u003e\n\n\u003cp\u003e138. CStone Pharmaceuticals\u003c\/p\u003e\n\n\u003cp\u003e139. CuraVac\u003c\/p\u003e\n\n\u003cp\u003e140. CureTech\u003c\/p\u003e\n\n\u003cp\u003e141. CytoDyn\u003c\/p\u003e\n\n\u003cp\u003e142. Daikyo Seiko\u003c\/p\u003e\n\n\u003cp\u003e143. Datwyler\u003c\/p\u003e\n\n\u003cp\u003e144. Debiotech\u003c\/p\u003e\n\n\u003cp\u003e145. DEKA\u003c\/p\u003e\n\n\u003cp\u003e146. Dekkun\u003c\/p\u003e\n\n\u003cp\u003e147. Delta-Fly Pharma\u003c\/p\u003e\n\n\u003cp\u003e148. Dendreon\u003c\/p\u003e\n\n\u003cp\u003e149. Dermira\u003c\/p\u003e\n\n\u003cp\u003e150. Desentum\u003c\/p\u003e\n\n\u003cp\u003e151. DexCom\u003c\/p\u003e\n\n\u003cp\u003e152. Diabeloop\u003c\/p\u003e\n\n\u003cp\u003e153. DiaMedica Therapeutics\u003c\/p\u003e \n\n\u003cp\u003e154. Dicerna Pharmaceuticals\u003c\/p\u003e\n\n\u003cp\u003e155. DreaMed Diabetes\u003c\/p\u003e\n\n\u003cp\u003e156. Duke Clinical Research Institute\u003c\/p\u003e \n\n\u003cp\u003e157. Duke University\u003c\/p\u003e\n\n\u003cp\u003e158. E3D Elcam Drug Delivery Devices\u003c\/p\u003e\n\n\u003cp\u003e159. ECHAlliance\u003c\/p\u003e\n\n\u003cp\u003e160. Eddingpharm\u003c\/p\u003e\n\n\u003cp\u003e161. Eiger BioPharmaceuticals\u003c\/p\u003e\n\n\u003cp\u003e162. Eisai\u003c\/p\u003e\n\n\u003cp\u003e163. Eitan Group\u003c\/p\u003e\n\n\u003cp\u003e164. Elcam group\u003c\/p\u003e\n\n\u003cp\u003e165. Eli Lilly\u003c\/p\u003e\n\n\u003cp\u003e166. Elusys Therapeutics\u003c\/p\u003e\n\n\u003cp\u003e167. EMD Serono\u003c\/p\u003e\n\n\u003cp\u003e168. Emergent BioSolutions\u003c\/p\u003e\n\n\u003cp\u003e169. Enable Injections\u003c\/p\u003e\n\n\u003cp\u003e170. Endocyte\u003c\/p\u003e\n\n\u003cp\u003e171. EnGeneIC\u003c\/p\u003e \n\n\u003cp\u003e172. EOC Pharma\u003c\/p\u003e\n\n\u003cp\u003e173. EOFlow\u003c\/p\u003e\n\n\u003cp\u003e174. EpicentRx\u003c\/p\u003e\n\n\u003cp\u003e175. Equillium\u003c\/p\u003e\n\n\u003cp\u003e176. Eris Lifesciences\u003c\/p\u003e\n\n\u003cp\u003e177. Etubics\u003c\/p\u003e\n\n\u003cp\u003e178. EVER Pharma\u003c\/p\u003e\n\n\u003cp\u003e179. Ever Supreme Bio Technology\u003c\/p\u003e\n\n\u003cp\u003e180. Evidation Health\u003c\/p\u003e\n\n\u003cp\u003e181. F2G\u003c\/p\u003e \n\n\u003cp\u003e182. Fabrico\u003c\/p\u003e\n\n\u003cp\u003e183. Ferring Pharmaceuticals\u003c\/p\u003e\n\n\u003cp\u003e184. FibroGen\u003c\/p\u003e\n\n\u003cp\u003e185. Fitbit\u003c\/p\u003e\n\n\u003cp\u003e186. Five Prime Therapeutics\u003c\/p\u003e\n\n\u003cp\u003e187. Flex Pharma\u003c\/p\u003e\n\n\u003cp\u003e188. Flextronics\u003c\/p\u003e\n\n\u003cp\u003e189. Flowonix Medical\u003c\/p\u003e\n\n\u003cp\u003e190. Galaxy Biotech\u003c\/p\u003e\n\n\u003cp\u003e191. Galena Biopharma\u003c\/p\u003e\n\n\u003cp\u003e192. GENCO\u003c\/p\u003e\n\n\u003cp\u003e193. GeneCure Biotechnologies\u003c\/p\u003e\n\n\u003cp\u003e194. Genentech (Roche)\u003c\/p\u003e\n\n\u003cp\u003e195. GENERON\u003c\/p\u003e\n\n\u003cp\u003e196. GeneScience Pharmaceuticals\u003c\/p\u003e\n\n\u003cp\u003e197. Genexine\u003c\/p\u003e\n\n\u003cp\u003e198. Genocea Biosciences\u003c\/p\u003e\n\n\u003cp\u003e199. Genor Biopharma\u003c\/p\u003e\n\n\u003cp\u003e200. Genzyme\u003c\/p\u003e\n\n\u003cp\u003e201. Georgia Institute of Technology\u003c\/p\u003e\n\n\u003cp\u003e202. Gerresheimer\u003c\/p\u003e\n\n\u003cp\u003e203. Gilead Sciences\u003c\/p\u003e\n\n\u003cp\u003e204. GlaxoSmithKline\u003c\/p\u003e\n\n\u003cp\u003e205. Glenmark Pharmaceuticals\u003c\/p\u003e\n\n\u003cp\u003e206. Gliknik\u003c\/p\u003e\n\n\u003cp\u003e207. GlobeImmune\u003c\/p\u003e\n\n\u003cp\u003e208. Glooko\u003c\/p\u003e\n\n\u003cp\u003e209. GLyPharma Therapeutic\u003c\/p\u003e\n\n\u003cp\u003e210. Guangzhou Cellprotek Pharmaceutical\u003c\/p\u003e\n\n\u003cp\u003e211. HAL Allergy\u003c\/p\u003e\n\n\u003cp\u003e212. Halozyme Therapeutics\u003c\/p\u003e\n\n\u003cp\u003e213. HanAll Biopharma\u003c\/p\u003e\n\n\u003cp\u003e214. Hanmi Pharmaceutical\u003c\/p\u003e\n\n\u003cp\u003e215. Harbour BioMed\u003c\/p\u003e\n\n\u003cp\u003e216. Harvard Pilgrim Health Care\u003c\/p\u003e\n\n\u003cp\u003e217. Haselmeier\u003c\/p\u003e\n\n\u003cp\u003e218. HealthPrize Technologies\u003c\/p\u003e\n\n\u003cp\u003e219. Helsinn Healthcare\u003c\/p\u003e\n\n\u003cp\u003e220. Hepatera\u003c\/p\u003e \n\n\u003cp\u003e221. Hoffmann-La Roche\u003c\/p\u003e\n\n\u003cp\u003e222. Huabo Biopharm\u003c\/p\u003e\n\n\u003cp\u003e223. IBM Watson\u003c\/p\u003e\n\n\u003cp\u003e224. IDF Europe (International Diabetes Federation)\u003c\/p\u003e\n\n\u003cp\u003e225. ILTOO Pharma\u003c\/p\u003e\n\n\u003cp\u003e226. ImClone Systems\u003c\/p\u003e\n\n\u003cp\u003e227. Immatics Biotechnologies\u003c\/p\u003e\n\n\u003cp\u003e228. Immune Response BioPharma\u003c\/p\u003e\n\n\u003cp\u003e229. ImmunGene\u003c\/p\u003e\n\n\u003cp\u003e230. Immunocore\u003c\/p\u003e\n\n\u003cp\u003e231. ImmunoFrontier\u003c\/p\u003e\n\n\u003cp\u003e232. ImmunoGen\u003c\/p\u003e\n\n\u003cp\u003e233. Immunomedics\u003c\/p\u003e\n\n\u003cp\u003e234. Immunotope\u003c\/p\u003e\n\n\u003cp\u003e235. Immunovaccine\u003c\/p\u003e\n\n\u003cp\u003e236. ImmuPharma\u003c\/p\u003e\n\n\u003cp\u003e237. Immutep\u003c\/p\u003e\n\n\u003cp\u003e238. Implicit Bioscience\u003c\/p\u003e\n\n\u003cp\u003e239. Incuron\u003c\/p\u003e\n\n\u003cp\u003e240. Incyte\u003c\/p\u003e\n\n\u003cp\u003e241. INmune Bio\u003c\/p\u003e\n\n\u003cp\u003e242. Innate Pharma\u003c\/p\u003e\n\n\u003cp\u003e243. Innovent Biologics\u003c\/p\u003e\n\n\u003cp\u003e244. Inovio Pharmaceuticals\u003c\/p\u003e\n\n\u003cp\u003e245. Insulet\u003c\/p\u003e\n\n\u003cp\u003e246. iNtRON Biotechnology\u003c\/p\u003e\n\n\u003cp\u003e247. IO Biotech\u003c\/p\u003e\n\n\u003cp\u003e248. Ionis Pharmaceuticals\u003c\/p\u003e\n\n\u003cp\u003e249. Ipsen\u003c\/p\u003e\n\n\u003cp\u003e250. IQVIA Biotech\u003c\/p\u003e\n\n\u003cp\u003e251. ISA Pharmaceuticals\u003c\/p\u003e\n\n\u003cp\u003e252. iSense CGM\u003c\/p\u003e\n\n\u003cp\u003e253. ISU ABXIS\u003c\/p\u003e\n\n\u003cp\u003e254. Izana Bioscience\u003c\/p\u003e \n\n\u003cp\u003e255. Janssen\u003c\/p\u003e\n\n\u003cp\u003e256. Jerini\u003c\/p\u003e\n\n\u003cp\u003e257. JHL Biotech\u003c\/p\u003e\n\n\u003cp\u003e258. Jiangsu Hengrui Medicine\u003c\/p\u003e\n\n\u003cp\u003e259. Jiangsu T-Mab Biopharma\u003c\/p\u003e\n\n\u003cp\u003e260. Johnson \u0026amp; Johnson\u003c\/p\u003e\n\n\u003cp\u003e261. Jounce Therapeutics\u003c\/p\u003e\n\n\u003cp\u003e262. Juvenile Diabetes Research Foundation\u003c\/p\u003e\n\n\u003cp\u003e263. KaloBios Pharmaceuticals\u003c\/p\u003e\n\n\u003cp\u003e264. Kangstem Biotech\u003c\/p\u003e\n\n\u003cp\u003e265. Kinevant Sciences\u003c\/p\u003e\n\n\u003cp\u003e266. Kissei Pharmaceutical\u003c\/p\u003e\n\n\u003cp\u003e267. Klue\u003c\/p\u003e\n\n\u003cp\u003e268. Kura Oncology\u003c\/p\u003e\n\n\u003cp\u003e269. Kyowa Hakko Kirin\u003c\/p\u003e\n\n\u003cp\u003e270. Kyowa Hakko Kirin\u003c\/p\u003e\n\n\u003cp\u003e271. Labrys Biologics\u003c\/p\u003e\n\n\u003cp\u003e272. LEO Pharma\u003c\/p\u003e\n\n\u003cp\u003e273. Levicept\u003c\/p\u003e\n\n\u003cp\u003e274. LIB Therapeutics\u003c\/p\u003e\n\n\u003cp\u003e275. Luye Pharma\u003c\/p\u003e\n\n\u003cp\u003e276. MabVax Therapeutics\u003c\/p\u003e\n\n\u003cp\u003e277. MacroGenics\u003c\/p\u003e\n\n\u003cp\u003e278. Maruho\u003c\/p\u003e\n\n\u003cp\u003e279. Massachusetts Institute of Technology\u003c\/p\u003e\n\n\u003cp\u003e280. MedImmune\u003c\/p\u003e\n\n\u003cp\u003e281. Medimop Medical Projects\u003c\/p\u003e\n\n\u003cp\u003e282. Medipacs\u003c\/p\u003e\n\n\u003cp\u003e283. Medtronic\u003c\/p\u003e\n\n\u003cp\u003e284. Medtrum Technologies\u003c\/p\u003e\n\n\u003cp\u003e285. Menarini Diagnostics\u003c\/p\u003e\n\n\u003cp\u003e286. Merck\u003c\/p\u003e\n\n\u003cp\u003e287. Merck Sharp \u0026amp; Dohme\u003c\/p\u003e\n\n\u003cp\u003e288. Mercy Technology Services\u003c\/p\u003e\n\n\u003cp\u003e289. Mereo BioPharma\u003c\/p\u003e\n\n\u003cp\u003e290. Merrimack Pharmaceuticals\u003c\/p\u003e\n\n\u003cp\u003e291. Mersana Therapeutics\u003c\/p\u003e\n\n\u003cp\u003e292. Merus\u003c\/p\u003e\n\n\u003cp\u003e293. Merz Pharma\u003c\/p\u003e\n\n\u003cp\u003e294. MicroVAX\u003c\/p\u003e\n\n\u003cp\u003e295. Millennium Pharmaceuticals\u003c\/p\u003e\n\n\u003cp\u003e296. MiNA Therapeutics\u003c\/p\u003e\n\n\u003cp\u003e297. miRagen Therapeutics\u003c\/p\u003e\n\n\u003cp\u003e298. Mitsubishi Tanabe Pharma\u003c\/p\u003e\n\n\u003cp\u003e299. Mode Automated Glucose Control\u003c\/p\u003e\n\n\u003cp\u003e300. Moderna Therapeutics\u003c\/p\u003e\n\n\u003cp\u003e301. Molecular Partners\u003c\/p\u003e\n\n\u003cp\u003e302. Molecular Templates\u003c\/p\u003e\n\n\u003cp\u003e303. MolMed\u003c\/p\u003e\n\n\u003cp\u003e304. Montagu Private Equity\u003c\/p\u003e\n\n\u003cp\u003e305. Morphogenesis\u003c\/p\u003e\n\n\u003cp\u003e306. MorphoSys\u003c\/p\u003e\n\n\u003cp\u003e307. Morphotek\u003c\/p\u003e\n\n\u003cp\u003e308. Movi\u003c\/p\u003e\n\n\u003cp\u003e309. MTD Micro Molding\u003c\/p\u003e\n\n\u003cp\u003e310. MYR Pharmaceuticals\u003c\/p\u003e\n\n\u003cp\u003e311. mySugr (Acquired by Roche)\u003c\/p\u003e\n\n\u003cp\u003e312. NanoPass Technologies\u003c\/p\u003e\n\n\u003cp\u003e313. NantBioScience\u003c\/p\u003e\n\n\u003cp\u003e314. National Cancer Institute\u003c\/p\u003e\n\n\u003cp\u003e315. Naurex\u003c\/p\u003e\n\n\u003cp\u003e316. Navidea Biopharmaceuticals\u003c\/p\u003e\n\n\u003cp\u003e317. Nemera\u003c\/p\u003e\n\n\u003cp\u003e318. Neogenix Oncology\u003c\/p\u003e\n\n\u003cp\u003e319. Neon Therapeutics\u003c\/p\u003e\n\n\u003cp\u003e320. Neumedicines\u003c\/p\u003e\n\n\u003cp\u003e321. NeuroDerm\u003c\/p\u003e\n\n\u003cp\u003e322. New Zealand Medical \u0026amp; Scientific\u003c\/p\u003e\n\n\u003cp\u003e323. NGM Biopharmaceuticals\u003c\/p\u003e\n\n\u003cp\u003e324. Noble\u003c\/p\u003e\n\n\u003cp\u003e325. Nordic Bioscience\u003c\/p\u003e\n\n\u003cp\u003e326. Nordic Infucare\u003c\/p\u003e\n\n\u003cp\u003e327. Northern Biologics\u003c\/p\u003e\n\n\u003cp\u003e328. Novartis Pharmaceuticals\u003c\/p\u003e\n\n\u003cp\u003e329. Novimmune\u003c\/p\u003e\n\n\u003cp\u003e330. NOVO Engineering\u003c\/p\u003e\n\n\u003cp\u003e331. Novo Nordisk\u003c\/p\u003e\n\n\u003cp\u003e332. Nutrino Health (Acquired by Medtronic)\u003c\/p\u003e\n\n\u003cp\u003e333. OBI Pharma\u003c\/p\u003e\n\n\u003cp\u003e334. Octapharma\u003c\/p\u003e\n\n\u003cp\u003e335. OliX Pharmaceuticals\u003c\/p\u003e\n\n\u003cp\u003e336. Omeros\u003c\/p\u003e\n\n\u003cp\u003e337. Oncolix\u003c\/p\u003e\n\n\u003cp\u003e338. Oncology Venture\u003c\/p\u003e\n\n\u003cp\u003e339. OncoMed Pharmaceuticals\u003c\/p\u003e\n\n\u003cp\u003e340. OncoPep\u003c\/p\u003e\n\n\u003cp\u003e341. Oncopeptides\u003c\/p\u003e\n\n\u003cp\u003e342. Oncternal Therapeutics\u003c\/p\u003e\n\n\u003cp\u003e343. Oncurious\u003c\/p\u003e\n\n\u003cp\u003e344. Opexa Therapeutics\u003c\/p\u003e\n\n\u003cp\u003e345. OPKO Health\u003c\/p\u003e\n\n\u003cp\u003e346. Optimer Pharmaceuticals\u003c\/p\u003e\n\n\u003cp\u003e347. Orphan Technologies\u003c\/p\u003e\n\n\u003cp\u003e348. OSE Immunotherapeutics\u003c\/p\u003e\n\n\u003cp\u003e349. Otsuka Pharmaceutical\u003c\/p\u003e\n\n\u003cp\u003e350. Paion UK\u003c\/p\u003e\n\n\u003cp\u003e351. Panacea Biotec\u003c\/p\u003e\n\n\u003cp\u003e352. PercuSense\u003c\/p\u003e\n\n\u003cp\u003e353. Pfizer\u003c\/p\u003e\n\n\u003cp\u003e354. PharmaJet\u003c\/p\u003e\n\n\u003cp\u003e355. PharmaMar\u003c\/p\u003e\n\n\u003cp\u003e356. PharmaSens\u003c\/p\u003e\n\n\u003cp\u003e357. PhaseBio Pharmaceuticals\u003c\/p\u003e\n\n\u003cp\u003e358. Phillips-Medisize\u003c\/p\u003e\n\n\u003cp\u003e359. Philogen\u003c\/p\u003e\n\n\u003cp\u003e360. Phosplatin Therapeutics\u003c\/p\u003e\n\n\u003cp\u003e361. Pierre Fabre\u003c\/p\u003e\n\n\u003cp\u003e362. Pique Therapeutics\u003c\/p\u003e\n\n\u003cp\u003e363. Plus Therapeutics (formerly Cytori Therapeutics)\u003c\/p\u003e\n\n\u003cp\u003e364. Polaris Group\u003c\/p\u003e\n\n\u003cp\u003e365. Polyphor\u003c\/p\u003e\n\n\u003cp\u003e366. Prescient Therapeutics\u003c\/p\u003e\n\n\u003cp\u003e367. Prestige BioPharma\u003c\/p\u003e\n\n\u003cp\u003e368. Promedior\u003c\/p\u003e\n\n\u003cp\u003e369. Prometheus Laboratories\u003c\/p\u003e\n\n\u003cp\u003e370. ProSciento\u003c\/p\u003e\n\n\u003cp\u003e371. Protagonist Therapeutics\u003c\/p\u003e\n\n\u003cp\u003e372. Protalix Biotherapeutics\u003c\/p\u003e\n\n\u003cp\u003e373. Proven Process Medical Devices\u003c\/p\u003e \n\n\u003cp\u003e374. Provenance Biopharmaceuticals\u003c\/p\u003e\n\n\u003cp\u003e375. Pulmonary Hypertension Association\u003c\/p\u003e\n\n\u003cp\u003e376. Qu Biologics\u003c\/p\u003e\n\n\u003cp\u003e377. Qualcomm\u003c\/p\u003e\n\n\u003cp\u003e378. Quest PharmaTech\u003c\/p\u003e\n\n\u003cp\u003e379. Quintessence Biosciences\u003c\/p\u003e\n\n\u003cp\u003e380. Ratio Drug Delivery\u003c\/p\u003e\n\n\u003cp\u003e381. RAUMEDIC\u003c\/p\u003e\n\n\u003cp\u003e382. Recipharm\u003c\/p\u003e\n\n\u003cp\u003e383. Recro Pharma\u003c\/p\u003e\n\n\u003cp\u003e384. Regeneron Pharmaceuticals\u003c\/p\u003e\n\n\u003cp\u003e385. REM Systems\u003c\/p\u003e\n\n\u003cp\u003e386. REMD Biotherapeutics\u003c\/p\u003e\n\n\u003cp\u003e387. RemeGen\u003c\/p\u003e\n\n\u003cp\u003e388. Resolve Therapeutics\u003c\/p\u003e\n\n\u003cp\u003e389. rEVO Biologics\u003c\/p\u003e\n\n\u003cp\u003e390. Rhythm Pharmaceuticals\u003c\/p\u003e\n\n\u003cp\u003e391. Roehr pharmaceuticals\u003c\/p\u003e\n\n\u003cp\u003e392. ROXALL Medizin\u003c\/p\u003e\n\n\u003cp\u003e393. R-Pharm\u003c\/p\u003e\n\n\u003cp\u003e394. Rubin Medical\u003c\/p\u003e\n\n\u003cp\u003e395. RxActuator\u003c\/p\u003e\n\n\u003cp\u003e396. Safe Save Medical Cell Sciences \u0026amp; Technology\u003c\/p\u003e\n\n\u003cp\u003e397. Sagentia\u003c\/p\u003e\n\n\u003cp\u003e398. Samsung Bioepis\u003c\/p\u003e\n\n\u003cp\u003e399. Sandoz\u003c\/p\u003e\n\n\u003cp\u003e400. Sanofi\u003c\/p\u003e\n\n\u003cp\u003e401. Santarus\u003c\/p\u003e\n\n\u003cp\u003e402. Saol Therapeutics\u003c\/p\u003e\n\n\u003cp\u003e403. Savient Pharmaceuticals\u003c\/p\u003e\n\n\u003cp\u003e404. scPharmaceuticals\u003c\/p\u003e \n\n\u003cp\u003e405. Seattle Genetics\u003c\/p\u003e\n\n\u003cp\u003e406. Selecta Biosciences\u003c\/p\u003e\n\n\u003cp\u003e407. Selexys Pharmaceuticals\u003c\/p\u003e\n\n\u003cp\u003e408. Senseonics\u003c\/p\u003e\n\n\u003cp\u003e409. Sensile Medical\u003c\/p\u003e\n\n\u003cp\u003e410. Serina Therapeutics\u003c\/p\u003e\n\n\u003cp\u003e411. SFC Fluidics\u003c\/p\u003e\n\n\u003cp\u003e412. Shanghai JMT-Bio\u003c\/p\u003e\n\n\u003cp\u003e413. Shenzhen Salubris Pharmaceuticals\u003c\/p\u003e\n\n\u003cp\u003e414. Shionogi\u003c\/p\u003e\n\n\u003cp\u003e415. Shire\u003c\/p\u003e\n\n\u003cp\u003e416. SHL Medical\u003c\/p\u003e\n\n\u003cp\u003e417. Singularity University\u003c\/p\u003e\n\n\u003cp\u003e418. Sinocelltech\u003c\/p\u003e\n\n\u003cp\u003e419. SK Chemicals\u003c\/p\u003e \n\n\u003cp\u003e420. SMC Global\u003c\/p\u003e\n\n\u003cp\u003e421. Smiths Medical\u003c\/p\u003e\n\n\u003cp\u003e422. Sonceboz\u003c\/p\u003e\n\n\u003cp\u003e423. SOOIL Development\u003c\/p\u003e\n\n\u003cp\u003e424. Sorrel Medical\u003c\/p\u003e\n\n\u003cp\u003e425. SOTIO\u003c\/p\u003e\n\n\u003cp\u003e426. SPARK Strategic Ideas\u003c\/p\u003e\n\n\u003cp\u003e427. SQ Innovation\u003c\/p\u003e\n\n\u003cp\u003e428. SteadyMed Therapeutics\u003c\/p\u003e\n\n\u003cp\u003e429. Stealth BioTherapeutics\u003c\/p\u003e\n\n\u003cp\u003e430. Stemline Therapeutics\u003c\/p\u003e\n\n\u003cp\u003e431. Stevanato Group\u003c\/p\u003e\n\n\u003cp\u003e432. Subcuject\u003c\/p\u003e\n\n\u003cp\u003e433. Sumitomo Dainippon Pharma\u003c\/p\u003e\n\n\u003cp\u003e434. Sun Pharmaceutical Industries\u003c\/p\u003e\n\n\u003cp\u003e435. Sunovion Pharmaceuticals\u003c\/p\u003e\n\n\u003cp\u003e436. Swissfillon\u003c\/p\u003e\n\n\u003cp\u003e437. SymBio Pharmaceuticals\u003c\/p\u003e\n\n\u003cp\u003e438. Symphogen\u003c\/p\u003e\n\n\u003cp\u003e439. Synermore Biologics\u003c\/p\u003e\n\n\u003cp\u003e440. Syntimmune\u003c\/p\u003e\n\n\u003cp\u003e441. Syros Pharmaceuticals\u003c\/p\u003e\n\n\u003cp\u003e442. TaiMed Biologics\u003c\/p\u003e\n\n\u003cp\u003e443. Taiwan Liposome Company\u003c\/p\u003e\n\n\u003cp\u003e444. Takeda Pharmaceutical\u003c\/p\u003e\n\n\u003cp\u003e445. Tandem Diabetes Care\u003c\/p\u003e\n\n\u003cp\u003e446. Tanvex BioPharma\u003c\/p\u003e\n\n\u003cp\u003e447. Tarveda Therapeutics\u003c\/p\u003e\n\n\u003cp\u003e448. Teva Pharmaceutical\u003c\/p\u003e\n\n\u003cp\u003e449. TG Therapeutics\u003c\/p\u003e\n\n\u003cp\u003e450. Theras Group\u003c\/p\u003e\n\n\u003cp\u003e451. Theras Lifetech\u003c\/p\u003e\n\n\u003cp\u003e452. Tianjin SinoBiotech\u003c\/p\u003e\n\n\u003cp\u003e453. Tidepool\u003c\/p\u003e\n\n\u003cp\u003e454. Tolero Pharmaceuticals\u003c\/p\u003e\n\n\u003cp\u003e455. TRACON Pharmaceuticals\u003c\/p\u003e\n\n\u003cp\u003e456. Transgene\u003c\/p\u003e\n\n\u003cp\u003e457. Translational Sciences\u003c\/p\u003e\n\n\u003cp\u003e458. TREOS Bio\u003c\/p\u003e\n\n\u003cp\u003e459. Turnstone Biologics\u003c\/p\u003e\n\n\u003cp\u003e460. Tyndall National Institute\u003c\/p\u003e\n\n\u003cp\u003e461. TypeZero Technologies\u003c\/p\u003e\n\n\u003cp\u003e462. Uni-Bio Science Group\u003c\/p\u003e\n\n\u003cp\u003e463. Union Chimique Belge (UCB)\u003c\/p\u003e\n\n\u003cp\u003e464. United BioPharma\u003c\/p\u003e\n\n\u003cp\u003e465. United Therapeutics\u003c\/p\u003e\n\n\u003cp\u003e466. University of Hertfordshire\u003c\/p\u003e\n\n\u003cp\u003e467. University of Arizona\u003c\/p\u003e\n\n\u003cp\u003e468. University of Bern\u003c\/p\u003e\n\n\u003cp\u003e469. University of California\u003c\/p\u003e\n\n\u003cp\u003e470. University of Colorado\u003c\/p\u003e\n\n\u003cp\u003e471. University of Hertfordshire\u003c\/p\u003e\n\n\u003cp\u003e472. University of Texas MD Anderson Cancer Center\u003c\/p\u003e\n\n\u003cp\u003e473. University of Virginia\u003c\/p\u003e\n\n\u003cp\u003e474. University of Virginia Patent Foundation\u003c\/p\u003e\n\n\u003cp\u003e475. Vaccinex\u003c\/p\u003e\n\n\u003cp\u003e476. Vaccinogen\u003c\/p\u003e\n\n\u003cp\u003e477. Valtronic\u003c\/p\u003e\n\n\u003cp\u003e478. vasopharm BIOTECH\u003c\/p\u003e\n\n\u003cp\u003e479. VectivBio\u003c\/p\u003e\n\n\u003cp\u003e480. Verily Life Sciences\u003c\/p\u003e\n\n\u003cp\u003e481. Vetter Pharma\u003c\/p\u003e\n\n\u003cp\u003e482. ViaCyte\u003c\/p\u003e\n\n\u003cp\u003e483. ViCentra\u003c\/p\u003e\n\n\u003cp\u003e484. Viela Bio\u003c\/p\u003e\n\n\u003cp\u003e485. ViiV Healthcare\u003c\/p\u003e\n\n\u003cp\u003e486. Vir Biotechnology\u003c\/p\u003e\n\n\u003cp\u003e487. ViroMed Laboratories\u003c\/p\u003e\n\n\u003cp\u003e488. Visterra\u003c\/p\u003e\n\n\u003cp\u003e489. Vitareis\u003c\/p\u003e\n\n\u003cp\u003e490. Vivozon\u003c\/p\u003e\n\n\u003cp\u003e491. Weibel CDS\u003c\/p\u003e\n\n\u003cp\u003e492. West Pharmaceutical Services\u003c\/p\u003e\n\n\u003cp\u003e493. Wockhardt\u003c\/p\u003e\n\n\u003cp\u003e494. Xbiotech\u003c\/p\u003e\n\n\u003cp\u003e495. XEME Biopharma\u003c\/p\u003e\n\n\u003cp\u003e496. Xencor\u003c\/p\u003e\n\n\u003cp\u003e497. XOMA\u003c\/p\u003e\n\n\u003cp\u003e498. Ypsomed\u003c\/p\u003e\n\n\u003cp\u003e499. Zafgen\u003c\/p\u003e\n\n\u003cp\u003e500. Zealand Pharma\u003c\/p\u003e\n\n\u003cp\u003e501. Zensun\u003c\/p\u003e\n\n\u003cp\u003e502. Zollner\u003c\/p\u003e\n\n\u003cp\u003e503. Zuellig Pharma\u003c\/p\u003e\n\n\n\u003cp\u003ePlease note that the publisher limits purchases by consulting clients to either Consulting Company Team License or Global Site License for Entire Company. Any other selections will not be fulfilled by this publisher.\u003c\/p\u003e","brand":"Service Industrries","offers":[{"title":"August, 2021 \/ - \/ MCW16269561","offer_id":47706944995634,"sku":null,"price":1139.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/on-body-drug-delivery-devices-intellectual-property-landscape-focus-on-popular-relevant-prior-art-search-expressions-patent-valuation-pockets-of-innovation-white-spaces-and-key-applicant-profiles","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}